Drug intelligence / Profile preview

erinacine A

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intraperitoneal
01

Overview

**Erinacine A** is a naturally occurring diterpenoid isolated from the mycelium and fruiting bodies of the medicinal mushroom *Hericium erinaceus* (lion’s mane mushroom)[2][6]. It is best known for its **neuroprotective, neuroregenerative, antidepressant-like, anti-inflammatory, antioxidant, and anti-cancer properties**. Mechanistically, it promotes nerve growth factor (NGF) synthesis and has been shown to activate neurotrophic signaling (BDNF/TrkB/PI3K/Akt/GSK-3β), modulate monoamine neurotransmitter levels (dopamine, serotonin, norepinephrine), inhibit inflammatory mediators (NF-κB, IL-6, TNF-α, iNOS, MAPK), induce antioxidant pathways (Nrf2/HO-1/SOD1), and reduce amyloid-β accumulation associated with neurodegenerative processes[1][3][5][6].

Other names
(3aR,5aR,6S)-3a,5a-dimethyl-1-propan-2-yl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-2,3,4,5,6,7-hexahydrocyclohepta[e]indene-8-carbaldehydecyathane diterpene(+)-Erinacin A
02

Targets

SERT (Sodium-dependent serotonin transporter)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on erinacine A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on erinacine A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call